ATE160090T1 - Verwendung von l-carnitine und acyl-l-carnitinen zur behandlung von patienten die an aids- verwandten syndromen leiden und von asymptomatischen hiv-seropositiven patienten - Google Patents
Verwendung von l-carnitine und acyl-l-carnitinen zur behandlung von patienten die an aids- verwandten syndromen leiden und von asymptomatischen hiv-seropositiven patientenInfo
- Publication number
- ATE160090T1 ATE160090T1 AT93114235T AT93114235T ATE160090T1 AT E160090 T1 ATE160090 T1 AT E160090T1 AT 93114235 T AT93114235 T AT 93114235T AT 93114235 T AT93114235 T AT 93114235T AT E160090 T1 ATE160090 T1 AT E160090T1
- Authority
- AT
- Austria
- Prior art keywords
- carnitine
- acyl
- aids
- patients
- related syndromes
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 4
- 208000030507 AIDS Diseases 0.000 title abstract 3
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- -1 acyl L-carnitines Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 230000006680 metabolic alteration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM920693A IT1258491B (it) | 1992-09-24 | 1992-09-24 | Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE160090T1 true ATE160090T1 (de) | 1997-11-15 |
Family
ID=11401203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93114235T ATE160090T1 (de) | 1992-09-24 | 1993-09-06 | Verwendung von l-carnitine und acyl-l-carnitinen zur behandlung von patienten die an aids- verwandten syndromen leiden und von asymptomatischen hiv-seropositiven patienten |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5631288A (de) |
| EP (1) | EP0590355B1 (de) |
| JP (1) | JPH06227983A (de) |
| KR (1) | KR0136559B1 (de) |
| AT (1) | ATE160090T1 (de) |
| DE (1) | DE69315162T2 (de) |
| DK (1) | DK0590355T3 (de) |
| ES (1) | ES2110551T3 (de) |
| GR (1) | GR3025372T3 (de) |
| IT (1) | IT1258491B (de) |
| ZA (1) | ZA936300B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6922994A (en) * | 1993-06-21 | 1995-01-17 | Bernardini, Attilio | Use of acylcarnitin to treat illnesses caused by aids |
| IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
| IT1291127B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
| US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| US20080119386A1 (en) * | 2006-11-22 | 2008-05-22 | Carl Germano | Nutritional formula for athletes' recovery |
| ES2579229T3 (es) | 2007-03-13 | 2016-08-08 | Jds Therapeutics, Llc | Procedimientos y composiciones para la liberación sostenida de cromo |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| AU2017217466A1 (en) | 2016-02-11 | 2018-08-23 | Nutrition 21, Llc | Chromium containing compositions for improving health and fitness |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1143214B (it) * | 1981-07-09 | 1986-10-22 | Sigma Tau Ind Farmaceuti | Acil derivato della carnitina quale immunomodulatore |
| IT1157238B (it) * | 1982-10-29 | 1987-02-11 | Sigma Tau Ind Farmaceuti | Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile |
| US5272153A (en) * | 1986-12-31 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
-
1992
- 1992-09-24 IT ITRM920693A patent/IT1258491B/it active IP Right Grant
-
1993
- 1993-08-27 ZA ZA936300A patent/ZA936300B/xx unknown
- 1993-09-06 ES ES93114235T patent/ES2110551T3/es not_active Expired - Lifetime
- 1993-09-06 AT AT93114235T patent/ATE160090T1/de active
- 1993-09-06 EP EP93114235A patent/EP0590355B1/de not_active Expired - Lifetime
- 1993-09-06 DE DE69315162T patent/DE69315162T2/de not_active Expired - Lifetime
- 1993-09-06 DK DK93114235.0T patent/DK0590355T3/da active
- 1993-09-13 KR KR1019930018520A patent/KR0136559B1/ko not_active Expired - Fee Related
- 1993-09-24 JP JP5237790A patent/JPH06227983A/ja active Pending
-
1995
- 1995-01-09 US US08/370,357 patent/US5631288A/en not_active Expired - Lifetime
-
1997
- 1997-11-13 GR GR970402512T patent/GR3025372T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0590355A1 (de) | 1994-04-06 |
| ITRM920693A1 (it) | 1994-03-24 |
| HK1004910A1 (en) | 1998-12-11 |
| DK0590355T3 (da) | 1998-03-02 |
| ZA936300B (en) | 1995-02-27 |
| EP0590355B1 (de) | 1997-11-12 |
| DE69315162T2 (de) | 1998-03-12 |
| IT1258491B (it) | 1996-02-26 |
| ITRM920693A0 (it) | 1992-09-24 |
| GR3025372T3 (en) | 1998-02-27 |
| KR0136559B1 (ko) | 1998-04-25 |
| KR940006576A (ko) | 1994-04-25 |
| DE69315162D1 (de) | 1997-12-18 |
| ES2110551T3 (es) | 1998-02-16 |
| US5631288A (en) | 1997-05-20 |
| JPH06227983A (ja) | 1994-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| IE870194L (en) | Use of lithium compounds in senile dementia | |
| DE59102210D1 (de) | Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus. | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| ATE120954T1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids. | |
| IT1189097B (it) | Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi | |
| DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
| ATE160090T1 (de) | Verwendung von l-carnitine und acyl-l-carnitinen zur behandlung von patienten die an aids- verwandten syndromen leiden und von asymptomatischen hiv-seropositiven patienten | |
| ATE123944T1 (de) | Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen. | |
| ATE184788T1 (de) | Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer | |
| DE68926115D1 (de) | Verfahren zur behandlung von akne | |
| DK347289A (da) | Terapeutiske forbindelser | |
| ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
| GB9205670D0 (en) | New derivatives of physostigmine,their use and pharmaceutical formulations containing them | |
| ATE141506T1 (de) | Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff | |
| ATE66375T1 (de) | Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung. | |
| ATE70977T1 (de) | Medikamente fuer die behandlung von rheumatoider arthritis. | |
| ES8500055A1 (es) | Procedimiento para la obtencion de un medicamento a base de un derivado de pirazolinona. | |
| IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. | |
| RU97117562A (ru) | Способ лечения болезней пародонта |